참고문헌 (41)

1. Hormone Molecular Biology and Clinical Investigation Bargut 31 1 2017 10.1515/hmbci-2016-0051 Browning of white adipose tissue: Lessons from experimental models 

   상세보기

2. Advanced Drug Delivery Reviews Bottger 154 79 2020 10.1016/j.addr.2020.06.017 Lipid-based nanoparticle technologies for liver targeting 

   상세보기

3. Journal of Hepatology Castro 58 1 119 2013 10.1016/j.jhep.2012.08.008 miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease 

   상세보기

4. Hepatology Chalasani 67 1 328 2018 10.1002/hep.29367 The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases 

   상세보기

5. Science Cohen 305 5682 390 2004 10.1126/science.1099196 Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase 

   상세보기

6. Drugs Cvetkovic 67 6 935 2007 10.2165/00003495-200767060-00008 Exenatide: A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea) 

   상세보기

7. Progress in Polymer Science Dash 36 8 981 2011 10.1016/j.progpolymsci.2011.02.001 Chitosan-a versatile semi-synthetic polymer in biomedical applications 

   상세보기

8. Journal of Controlled Release de Oliveira Junior 321 540 2020 10.1016/j.jconrel.2020.02.033 Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 

   상세보기

9. Hepatology Ding 43 1 173 2006 10.1002/hep.21006 Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice 

   상세보기

10. Journal of Biological Chemistry Eisele 288 4 2246 2013 10.1074/jbc.M112.375253 The peroxisome proliferator-activated receptor gamma coactivator 1alpha/beta (PGC-1) coactivators repress the transcriptional activity of NF-kappaB in skeletal muscle cells 

    상세보기

11. Journal of Clinical Endocrinology and Metabolism Fehse 90 11 5991 2005 10.1210/jc.2005-1093 Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes 

    상세보기

12. Journal of Hepatology Fiorucci 39 6 932 2003 10.1016/S0168-8278(03)00393-3 NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver 

    상세보기

13. Nature Medicine Friedman 24 7 908 2018 10.1038/s41591-018-0104-9 Mechanisms of NAFLD development and therapeutic strategies 

    상세보기

14. Molecular Cell Gerhart-Hines 44 6 851 2011 10.1016/j.molcel.2011.12.005 The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+) 

    상세보기

15. Scandinavian Journal of Gastroenterology. Supplement Hofmann 204 1 1994 10.3109/00365529409103618 Pharmacology of ursodeoxycholic acid, an enterohepatic drug 

    상세보기

16. Angewandte Chemie International Edition Jurcˇek 54 51 15462 2015 10.1002/anie.201506539 Superchiral Pd3L6 coordination complex and its reversible structural conversion into Pd3L3Cl6 metallocycles 

    상세보기

17. Proceedings of the National Academy of Sciences of the United States of America Kamei 100 21 12378 2003 10.1073/pnas.2135217100 PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity 

    상세보기

18. Cells Kosgei 9 8 2020 10.3390/cells9081882 Sirt1-PPARS cross-talk in complex metabolic diseases and inherited disorders of the one carbon metabolism 

    상세보기

19. Journal of Controlled Release Lee 161 3 728 2012 10.1016/j.jconrel.2012.05.029 Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system 

    상세보기

20. Cell Lin 120 2 261 2005 10.1016/j.cell.2004.11.043 Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP 

    상세보기

21. Biomaterials Noh 32 3 849 2011 10.1016/j.biomaterials.2010.09.027 Tocopheryl oligochitosan-based self assembling oligomersomes for siRNA delivery 

    상세보기

22. Nanoscale Pramod 7 15 6636 2015 10.1039/C5NR00799B Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells 

    상세보기

23. Biomacromolecules Pramod 13 11 3627 2012 10.1021/bm301583s Dextran vesicular carriers for dual encapsulation of hydrophilic and hydrophobic molecules and delivery into cells 

    상세보기

24. Cell Qiang 150 3 620 2012 10.1016/j.cell.2012.06.027 Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of ppargamma 

    상세보기

25. Nutrients Rafiei 11 3 2019 10.3390/nu11030541 Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function 

    상세보기

26. Trends in Biochemical Sciences Revollo 38 3 160 2013 10.1016/j.tibs.2012.12.004 The ways and means that fine tune Sirt1 activity 

    상세보기

27. Pharmacological Research Roda 23 4 327 1991 10.1016/1043-6618(91)90048-3 Pharmacokinetics of ursodeoxycholic acid in rat 

    상세보기

28. Gut Rotman 66 1 180 2017 10.1136/gutjnl-2016-312431 Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease 

    상세보기

29. Carbohydrate Polymers Sarkar 247 2020 10.1016/j.carbpol.2020.116594 Chitosan: A promising therapeutic agent and effective drug delivery system in managing diabetes mellitus 

    상세보기

30. Nature Biotechnology Schellenberger 27 12 1186 2009 10.1038/nbt.1588 A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner 

    상세보기

31. Journal of Endocrinology Sugden 204 2 93 2010 10.1677/JOE-09-0359 PPAR control: it's SIRTainly as easy as PGC 

    상세보기

32. Journal of Gastroenterology Sumida 53 3 362 2018 10.1007/s00535-017-1415-1 Current and future pharmacological therapies for NAFLD/NASH 

    상세보기

33. Liver International Svegliati-Baroni 31 9 1285 2011 10.1111/j.1478-3231.2011.02462.x Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 

    상세보기

34. Hepatology Tilg 52 5 1836 2010 10.1002/hep.24001 Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis 

    상세보기

35. Tolosa 333 2015 Protocols in in vitro hepatocyte research General cytotoxicity assessment by means of the MTT assay 

36. Annual Review of Biochemistry Tontonoz 77 289 2008 10.1146/annurev.biochem.77.061307.091829 Fat and beyond: The diverse biology of PPAR gamma 

    상세보기

37. Molecular and Cellular Biology Vega 20 5 1868 2000 10.1128/MCB.20.5.1868-1876.2000 The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes 

    상세보기

38. Cells Wagner 9 11 2020 10.3390/cells9112367 The role of PPARs in disease 

    상세보기

39. Hepatology Wegermann 73 4 2021 Letter to the editor: Tackling NAFLD in adolescent polycystic ovary syndrome: Reducing liver fat to mimic weight loss reply 

40. Diabetes Xu 63 11 3637 2014 10.2337/db14-0263 SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis 

    상세보기

41. Hepatology Younossi 64 1 73 2016 10.1002/hep.28431 Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes 

    상세보기